Informations sur le produit
LEI401 is a drug that inhibits the Wnt/β-catenin signaling pathway. LEI401 has been shown to inhibit the growth of cancer cells in vitro and in animal models. It also shows efficacy against other types of cancers, such as leukemia and lymphoma, with possible applications for treatments of tumors. LEI401 is currently under investigation for its potential to treat Alzheimer's disease and Huntington's disease. In addition, LEI401 has been shown to have anthelmintic activity against nematodes (roundworms). The drug targets proteasomes in nematodes and causes premature protein degradation, leading to cell death.
Propriétés chimiques
Question d’ordre technique sur : 3D-BL178105 LEI401
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages
